Follow The Filings

RJF Raymond James

Raymond James earnings company data as of 5:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 3.39 — —
Rev — — —

Insider trades

Open-market buys and sales by RJF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RJF insider trades
  • None no insider bought on the open market
  • $30.4M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Bella Loykhter Allaire Chief Admin Officer
    Sale
    $1.3M 7,500 shares at $177.60 14% of stake
    Traded Aug 28 Filed Aug 31
  2. Tashtego S Elwyn President, PCG
    Sale
    $1.8M 10,000 shares at $176.06 18% of stake
    Traded Jul 28 Filed Jul 29
  3. Steven M Raney Chair
    Sale
    $998K 5,770 shares at $172.97 12% of stake
    Traded Jul 27 Filed Jul 28
  4. Bella Loykhter Allaire Chief Admin Officer
    Sale
    $4.2M 29,551 shares at $142.34 36% of stake
    Traded Mar 19 Filed Mar 20
  5. Jonathan N Santelli EVP, General Counsel
    Sale
    $767K 4,500 shares at $170.46 14% of stake
    Traded Feb 4 Filed Feb 5
  6. Paul C Reilly Chair
    Sale
    $21.3M 130,687 shares at $163.15 33% of stake
    Traded Dec 15, 2025 Filed Dec 15, 2025

Also filed in the last 12 months, not counted as buying or selling: 77 share withholdings for taxes, 72 option exercises, 19 gifts, and 18 stock grants.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 5.02,7.01
8-K 7.01,9.01
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
10-Q
SCHEDULE 13G —
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 5.07,7.01,9.01
8-K 7.01,9.01
10-Q
DEFA14A
8-K 2.02,9.01
8-K 8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.